Bill Text: TX HB4408 | 2021-2022 | 87th Legislature | Introduced
Bill Title: Relating to provision of an opioid antagonist to a person who is filling a prescription for an opioid medication.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2021-03-29 - Referred to Public Health [HB4408 Detail]
Download: Texas-2021-HB4408-Introduced.html
| 87R12346 JSC-F | ||
| By: Price | H.B. No. 4408 | |
|
|
||
|
|
||
| relating to provision of an opioid antagonist to a person who is | ||
| filling a prescription for an opioid medication. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Section 483.103, Health and Safety Code, is | ||
| amended by adding Subsection (b-1) and amending Subsection (c) to | ||
| read as follows: | ||
| (b-1) A pharmacist may dispense an opioid antagonist | ||
| without a prescription to a person to whom the pharmacist is | ||
| dispensing an opioid medication under a prescription if: | ||
| (1) the opioid is prescribed in conjunction with | ||
| benzodiazepine medication; | ||
| (2) the prescription of the dispensed medication | ||
| directs the patient to take 90 morphine milligram equivalents or | ||
| more daily; | ||
| (3) in the pharmacist's professional opinion, the | ||
| patient is at risk of accidental overdose or potential abuse or | ||
| overuse; or | ||
| (4) the physician who issued the prescription has | ||
| communicated to the pharmacist that in the physician's professional | ||
| opinion, the patient is at risk of accidental overdose or potential | ||
| abuse or overuse. | ||
| (c) A pharmacist who, acting in good faith and with | ||
| reasonable care, dispenses or does not dispense an opioid | ||
| antagonist under a valid prescription or on the pharmacist's own | ||
| initiative under Subsection (b-1) is not subject to any criminal or | ||
| civil liability or any professional disciplinary action for: | ||
| (1) dispensing or failing to dispense the opioid | ||
| antagonist; or | ||
| (2) if the pharmacist chooses to dispense an opioid | ||
| antagonist, any outcome resulting from the eventual administration | ||
| of the opioid antagonist. | ||
| SECTION 2. The change in law made by this Act applies only | ||
| to a person to whom the pharmacist dispenses an opioid medication | ||
| under a prescription on or after the effective date of this Act. | ||
| SECTION 3. This Act takes effect September 1, 2021. | ||
